GeneOne Life Science, Inc. (KRX:011000)
South Korea
· Delayed Price · Currency is KRW 848.00
-68.00 (-7.42%)
Last updated: Apr 29, 2026, 1:49 PM KST
GeneOne Life Science Revenue
In the year 2025, GeneOne Life Science had annual revenue of 23.04B KRW, down -35.49%. GeneOne Life Science had revenue of 2.65B in the quarter ending December 31, 2025, a decrease of -74.76%.
Revenue
23.04B
Revenue Growth
-35.49%
P/S Ratio
3.34
Revenue / Employee
562.07M
Employees
41
Market Cap
77.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.04B | -12.68B | -35.49% |
| Dec 31, 2024 | 35.72B | -4.48B | -11.15% |
| Dec 31, 2023 | 40.20B | -8.52B | -17.48% |
| Dec 31, 2022 | 48.72B | 10.02B | 25.89% |
| Dec 31, 2021 | 38.70B | -2.80B | -6.75% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IMB Dx | 5.33B |
| CG Invites | 27.39B |
| Oncocross | 370.46M |
| ORIENT BIO | 59.09B |
| iNtRON Biotechnology | 5.74B |
| Amicogen | 41.98B |
| ENCell | 5.26B |
| Vaxcell-Bio Therapeutics | 1.90B |